Interferon-λ: Immune Functions at Barrier Surfaces and Beyond

Alexopoulou, 2015, Interferon-based combination treatment for chronic hepatitis C in the era of direct acting antivirals, Ann. Gastroenterol., 28, 55 Angel, 1999, Lack of a role for type I and type II interferons in the resolution of rotavirus-induced diarrhea and infection in mice, J. Interferon Cytokine Res., 19, 655, 10.1089/107999099313802 Ank, 2006, Lambda interferon (IFN-lambda), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo, J. Virol., 80, 4501, 10.1128/JVI.80.9.4501-4509.2006 Ank, 2008, An important role for type III interferon (IFN-lambda/IL-28) in TLR-induced antiviral activity, J. Immunol., 180, 2474, 10.4049/jimmunol.180.4.2474 Baker, 2013, Antiviral immune responses of bats: a review, Zoonoses Public Health, 60, 104, 10.1111/j.1863-2378.2012.01528.x Baldridge, 2015, Commensal microbes and interferon-λ determine persistence of enteric murine norovirus infection, Science, 347, 266, 10.1126/science.1258025 Bandi, 2010, Inhibition of type III interferon activity by orthopoxvirus immunomodulatory proteins, J. Interferon Cytokine Res., 30, 123, 10.1089/jir.2009.0049 Baños-Lara, 2015, Impact and regulation of lambda interferon response in human metapneumovirus infection, J. Virol., 89, 730, 10.1128/JVI.02897-14 Bibert, 2013, IL28B expression depends on a novel TT/-G polymorphism which improves HCV clearance prediction, J. Exp. Med., 210, 1109, 10.1084/jem.20130012 Bibert, 2014, The IFNL3/4 ΔG variant increases susceptibility to cytomegalovirus retinitis among HIV-infected patients, AIDS, 28, 1885, 10.1097/QAD.0000000000000379 Bierne, 2012, Activation of type III interferon genes by pathogenic bacteria in infected epithelial cells and mouse placenta, PLoS ONE, 7, e39080, 10.1371/journal.pone.0039080 Blazek, 2015, IFN-λ resolves inflammation via suppression of neutrophil infiltration and IL-1β production, J. Exp. Med., 212, 845, 10.1084/jem.20140995 Bok, 2012, Norovirus gastroenteritis in immunocompromised patients, N. Engl. J. Med., 367, 2126, 10.1056/NEJMra1207742 Bolen, 2014, Dynamic expression profiling of type I and type III interferon-stimulated hepatocytes reveals a stable hierarchy of gene expression, Hepatology, 59, 1262, 10.1002/hep.26657 Booy, 2015, Potentials of interferon therapy in the treatment of pancreatic cancer, J. Interferon Cytokine Res., 35, 327, 10.1089/jir.2014.0157 Burkart, 2013, Usp18 deficient mammary epithelial cells create an antitumour environment driven by hypersensitivity to IFN-λ and elevated secretion of Cxcl10, EMBO Mol. Med., 5, 967, 10.1002/emmm.201201864 Cannella, 2014, Interferon lambda 1 expression in cervical cells differs between low-risk and high-risk human papillomavirus-positive women, Med. Microbiol. Immunol. (Berl.), 203, 177, 10.1007/s00430-014-0330-9 Christophers, 1987, Contrasting disease patterns in psoriasis and atopic dermatitis, Arch. Dermatol. Res., 279, S48, 10.1007/BF00585919 Clark, 2013, Human skin in the game, Sci. Transl. Med., 5, 204ps13, 10.1126/scitranslmed.3007504 Coccia, 2004, Viral infection and Toll-like receptor agonists induce a differential expression of type I and lambda interferons in human plasmacytoid and monocyte-derived dendritic cells, Eur. J. Immunol., 34, 796, 10.1002/eji.200324610 Cohen, 2013, Bacterial pathogens activate a common inflammatory pathway through IFNλ regulation of PDCD4, PLoS Pathog., 9, e1003682, 10.1371/journal.ppat.1003682 Contoli, 2006, Role of deficient type III interferon-lambda production in asthma exacerbations, Nat. Med., 12, 1023, 10.1038/nm1462 Crotta, 2013, Type I and type III interferons drive redundant amplification loops to induce a transcriptional signature in influenza-infected airway epithelia, PLoS Pathog., 9, e1003773, 10.1371/journal.ppat.1003773 Crow, 2015, Type I interferonopathies: mendelian type I interferon up-regulation, Curr. Opin. Immunol., 32, 7, 10.1016/j.coi.2014.10.005 Dai, 2009, IFN-lambda1 (IL-29) inhibits GATA3 expression and suppresses Th2 responses in human naive and memory T cells, Blood, 113, 5829, 10.1182/blood-2008-09-179507 Daniels, 2014, Viral pathogen-associated molecular patterns regulate blood-brain barrier integrity via competing innate cytokine signals, MBio, 5, 10.1128/mBio.01476-14 Dellgren, 2009, Human interferon-lambda3 is a potent member of the type III interferon family, Genes Immun., 10, 125, 10.1038/gene.2008.87 Dickensheets, 2013, Interferon-lambda (IFN-λ) induces signal transduction and gene expression in human hepatocytes, but not in lymphocytes or monocytes, J. Leukoc. Biol., 93, 377, 10.1189/jlb.0812395 Di Trolio, 2015, The use of interferon in melanoma patients: a systematic review, Cytokine Growth Factor Rev., 26, 203, 10.1016/j.cytogfr.2014.11.008 Donnelly, 2010, Interferon-lambda: a new addition to an old family, J. Interferon Cytokine Res., 30, 555, 10.1089/jir.2010.0078 Donnelly, 2011, Interferon-lambda and therapy for chronic hepatitis C virus infection, Trends Immunol., 32, 443, 10.1016/j.it.2011.07.002 Doyle, 2006, Interleukin-29 uses a type 1 interferon-like program to promote antiviral responses in human hepatocytes, Hepatology, 44, 896, 10.1002/hep.21312 Dumoutier, 2004, Role of the interleukin (IL)-28 receptor tyrosine residues for antiviral and antiproliferative activity of IL-29/interferon-lambda 1: similarities with type I interferon signaling, J. Biol. Chem., 279, 32269, 10.1074/jbc.M404789200 Durbin, 2013, Interferon induction and function at the mucosal surface, Immunol. Rev., 255, 25, 10.1111/imr.12101 Egli, 2014, Immunomodulatory Function of Interleukin 28B during primary infection with cytomegalovirus, J. Infect. Dis., 210, 717, 10.1093/infdis/jiu144 Egli, 2014, IL-28B is a key regulator of B- and T-cell vaccine responses against influenza, PLoS Pathog., 10, e1004556, 10.1371/journal.ppat.1004556 Egli, 2014, The impact of the interferon-lambda family on the innate and adaptive immune response to viral infections, Emerg Microbes Infect, 3, e51, 10.1038/emi.2014.51 Epperson, 2012, Subversion of cytokine networks by virally encoded decoy receptors, Immunol. Rev., 250, 199, 10.1111/imr.12009 Eslam, 2015, Interferon-λ rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease, Nat. Commun., 6, 6422, 10.1038/ncomms7422 Forrest, 2003, Reovirus receptors and pathogenesis, J. Virol., 77, 9109, 10.1128/JVI.77.17.9109-9115.2003 Fox, 2015, Interferon Lambda Upregulates IDO1 Expression in Respiratory Epithelial Cells After Influenza Virus Infection, J. Interferon Cytokine Res., 10.1089/jir.2014.0052 François-Newton, 2011, USP18-based negative feedback control is induced by type I and type III interferons and specifically inactivates interferon α response, PLoS ONE, 6, e22200, 10.1371/journal.pone.0022200 Gad, 2009, Interferon-lambda is functionally an interferon but structurally related to the interleukin-10 family, J. Biol. Chem., 284, 20869, 10.1074/jbc.M109.002923 Gallagher, 2010, The lambda interferons: guardians of the immune-epithelial interface and the T-helper 2 response, J. Interferon Cytokine Res., 30, 603, 10.1089/jir.2010.0081 Galmozzi, 2014, Systematic review with meta-analysis: do interferon lambda 3 polymorphisms predict the outcome of interferon-therapy in hepatitis B infection?, Aliment. Pharmacol. Ther., 39, 569, 10.1111/apt.12631 Ge, 2009, Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance, Nature, 461, 399, 10.1038/nature08309 Génin, 2009, Differential regulation of human interferon A gene expression by interferon regulatory factors 3 and 7, Mol. Cell. Biol., 29, 3435, 10.1128/MCB.01805-08 Grayfer, 2015, Prominent amphibian (Xenopus laevis) tadpole type III interferon response to the frog virus 3 ranavirus, J. Virol., 89, 5072, 10.1128/JVI.00051-15 Griffiths, 2013, A systematic analysis of host factors reveals a Med23-interferon-λ regulatory axis against herpes simplex virus type 1 replication, PLoS Pathog., 9, e1003514, 10.1371/journal.ppat.1003514 Griffiths, 2015, The Role of Interferon-λ Locus Polymorphisms in Hepatitis C and Other Infectious Diseases, J. Innate Immun., 7, 231, 10.1159/000369902 Hamming, 2013, Interferon lambda 4 signals via the IFNλ receptor to regulate antiviral activity against HCV and coronaviruses, EMBO J., 32, 3055, 10.1038/emboj.2013.232 Haralambieva, 2011, Associations between single nucleotide polymorphisms and haplotypes in cytokine and cytokine receptor genes and immunity to measles vaccination, Vaccine, 29, 7883, 10.1016/j.vaccine.2011.08.083 Hayes, 2012, Genetics of IL28B and HCV--response to infection and treatment, Nat. Rev. Gastroenterol. Hepatol., 9, 406, 10.1038/nrgastro.2012.101 Hermant, 2014, Interferon-λ in the context of viral infections: production, response and therapeutic implications, J. Innate Immun., 6, 563, 10.1159/000360084 Hermant, 2014, Human but not mouse hepatocytes respond to interferon-lambda in vivo, PLoS ONE, 9, e87906, 10.1371/journal.pone.0087906 Hernández, 2015, Interferon-λ and interleukin 22 act synergistically for the induction of interferon-stimulated genes and control of rotavirus infection, Nat. Immunol., 16, 698, 10.1038/ni.3180 Hillyer, 2012, Expression profiles of human interferon-alpha and interferon-lambda subtypes are ligand- and cell-dependent, Immunol. Cell Biol., 90, 774, 10.1038/icb.2011.109 Hoffmann, 2015, Interferons and viruses: an evolutionary arms race of molecular interactions, Trends Immunol., 36, 124, 10.1016/j.it.2015.01.004 Huang, 2007, Inhibition of type I and type III interferons by a secreted glycoprotein from Yaba-like disease virus, Proc. Natl. Acad. Sci. USA, 104, 9822, 10.1073/pnas.0610352104 Isaacs, 1957, Virus interference. I. The interferon, Proc. R. Soc. Lond. B Biol. Sci., 147, 258, 10.1098/rspb.1957.0048 Iversen, 2010, Mechanisms of type III interferon expression, J. Interferon Cytokine Res., 30, 573, 10.1089/jir.2010.0063 Iversen, 2010, Expression of type III interferon (IFN) in the vaginal mucosa is mediated primarily by dendritic cells and displays stronger dependence on NF-kappaB than type I IFNs, J. Virol., 84, 4579, 10.1128/JVI.02591-09 Jewell, 2010, Lambda interferon is the predominant interferon induced by influenza A virus infection in vivo, J. Virol., 84, 11515, 10.1128/JVI.01703-09 Jones, 2014, Enteric bacteria promote human and mouse norovirus infection of B cells, Science, 346, 755, 10.1126/science.1257147 Jordan, 2007, Modulation of the human cytokine response by interferon lambda-1 (IFN-lambda1/IL-29), Genes Immun., 8, 13, 10.1038/sj.gene.6364348 Jordan, 2007, Human interferon lambda-1 (IFN-lambda1/IL-29) modulates the Th1/Th2 response, Genes Immun., 8, 254, 10.1038/sj.gene.6364382 Kane, 2011, Successful transmission of a retrovirus depends on the commensal microbiota, Science, 334, 245, 10.1126/science.1210718 Karst, 2014, Advances in norovirus biology, Cell Host Microbe, 15, 668, 10.1016/j.chom.2014.05.015 Key, 2014, Selection on a variant associated with improved viral clearance drives local, adaptive pseudogenization of interferon lambda 4 (IFNL4), PLoS Genet., 10, e1004681, 10.1371/journal.pgen.1004681 Kim, 2013, Reactive oxygen species induce antiviral innate immune response through IFN-λ regulation in human nasal epithelial cells, Am. J. Respir. Cell Mol. Biol., 49, 855, 10.1165/rcmb.2013-0003OC Koch, 2015, Role of Interferon-λ in Allergic Asthma, J. Innate Immun., 7, 224, 10.1159/000369459 Kohli, 2012, Distinct and overlapping genomic profiles and antiviral effects of Interferon-λ and -α on HCV-infected and noninfected hepatoma cells, J. Viral Hepat., 19, 843, 10.1111/j.1365-2893.2012.01610.x Koltsida, 2011, IL-28A (IFN-λ2) modulates lung DC function to promote Th1 immune skewing and suppress allergic airway disease, EMBO Mol. Med., 3, 348, 10.1002/emmm.201100142 Kotenko, 2011, IFN-λs, Curr. Opin. Immunol., 23, 583, 10.1016/j.coi.2011.07.007 Kotenko, 2003, IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex, Nat. Immunol., 4, 69, 10.1038/ni875 Koyuncu, 2013, Virus infections in the nervous system, Cell Host Microbe, 13, 379, 10.1016/j.chom.2013.03.010 Kuss, 2011, Intestinal microbiota promote enteric virus replication and systemic pathogenesis, Science, 334, 249, 10.1126/science.1211057 Lampertico, 2013, IL28B polymorphisms predict interferon-related hepatitis B surface antigen seroclearance in genotype D hepatitis B e antigen-negative patients with chronic hepatitis B, Hepatology, 57, 890, 10.1002/hep.25749 Lasfar, 2006, Characterization of the mouse IFN-lambda ligand-receptor system: IFN-lambdas exhibit antitumor activity against B16 melanoma, Cancer Res., 66, 4468, 10.1158/0008-5472.CAN-05-3653 Lauterbach, 2010, Mouse CD8alpha+ DCs and human BDCA3+ DCs are major producers of IFN-lambda in response to poly IC, J. Exp. Med., 207, 2703, 10.1084/jem.20092720 Lazear, 2015, Interferon-λ restricts West Nile virus neuroinvasion by tightening the blood-brain barrier, Sci. Transl. Med., 7, 284ra59, 10.1126/scitranslmed.aaa4304 Lebreton, 2011, A bacterial protein targets the BAHD1 chromatin complex to stimulate type III interferon response, Science, 331, 1319, 10.1126/science.1200120 Leung, 2013, New insights into atopic dermatitis: role of skin barrier and immune dysregulation, Allergol. Int., 62, 151, 10.2332/allergolint.13-RAI-0564 Li, 2008, Regulation of apoptosis by type III interferons, Cell Prolif., 41, 960, 10.1111/j.1365-2184.2008.00558.x Li, 2013, Association analyses identifying two common susceptibility loci shared by psoriasis and systemic lupus erythematosus in the Chinese Han population, J. Med. Genet., 50, 812, 10.1136/jmedgenet-2013-101787 Lopez, 2006, Early steps in rotavirus cell entry, Curr. Top. Microbiol. Immunol., 309, 39 Lopez de Lapuente, 2012, Analysis of the IL28RA locus as genetic risk factor for multiple sclerosis, J. Neuroimmunol., 245, 98, 10.1016/j.jneuroim.2012.02.005 Love, 2014, Borrelia burgdorferi RNA induces type I and III interferons via Toll-like receptor 7 and contributes to production of NF-κB-dependent cytokines, Infect. Immun., 82, 2405, 10.1128/IAI.01617-14 Ma, 2009, Antiviral effect of interferon lambda against West Nile virus, Antiviral Res., 83, 53, 10.1016/j.antiviral.2009.03.006 Mahlakõiv, 2012, Combined action of type I and type III interferon restricts initial replication of severe acute respiratory syndrome coronavirus in the lung but fails to inhibit systemic virus spread, J. Gen. Virol., 93, 2601, 10.1099/vir.0.046284-0 Mahlakõiv, 2015, Leukocyte-derived IFN-α/β and epithelial IFN-λ constitute a compartmentalized mucosal defense system that restricts enteric virus infections, PLoS Pathog., 11, e1004782, 10.1371/journal.ppat.1004782 Malhotra, 2011, IL28B polymorphisms are not associated with the response to interferon-β in multiple sclerosis, J. Neuroimmunol., 239, 101, 10.1016/j.jneuroim.2011.08.004 Manuel, 2015, Influence of IFNL3/4 polymorphisms on the incidence of cytomegalovirus infection after solid-organ transplantation, J. Infect. Dis., 211, 906, 10.1093/infdis/jiu557 Marcello, 2006, Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics, Gastroenterology, 131, 1887, 10.1053/j.gastro.2006.09.052 Markowitz, 2007, Interferon-beta: mechanism of action and dosing issues, Neurology, 68, S8, 10.1212/01.wnl.0000277703.74115.d2 Marukian, 2011, Hepatitis C virus induces interferon-λ and interferon-stimulated genes in primary liver cultures, Hepatology, 54, 1913, 10.1002/hep.24580 McFarland, 2014, The favorable IFNL3 genotype escapes mRNA decay mediated by AU-rich elements and hepatitis C virus-induced microRNAs, Nat. Immunol., 15, 72, 10.1038/ni.2758 Miknis, 2010, Crystal structure of human interferon-λ1 in complex with its high-affinity receptor interferon-λR1, J. Mol. Biol., 404, 650, 10.1016/j.jmb.2010.09.068 Misumi, 2014, IFN-λ exerts opposing effects on T cell responses depending on the chronicity of the virus infection, J. Immunol., 192, 3596, 10.4049/jimmunol.1301705 Mordstein, 2008, Interferon-lambda contributes to innate immunity of mice against influenza A virus but not against hepatotropic viruses, PLoS Pathog., 4, e1000151, 10.1371/journal.ppat.1000151 Mordstein, 2010, What have we learned from the IL28 receptor knockout mouse?, J. Interferon Cytokine Res., 30, 579, 10.1089/jir.2010.0061 Mordstein, 2010, Lambda interferon renders epithelial cells of the respiratory and gastrointestinal tracts resistant to viral infections, J. Virol., 84, 5670, 10.1128/JVI.00272-10 Morrow, 2009, Comparative ability of IL-12 and IL-28B to regulate Treg populations and enhance adaptive cellular immunity, Blood, 113, 5868, 10.1182/blood-2008-11-190520 Muir, 2014, A randomized phase 2b study of peginterferon lambda-1a for the treatment of chronic HCV infection, J. Hepatol., 61, 1238, 10.1016/j.jhep.2014.07.022 Nice, 2013, A single-amino-acid change in murine norovirus NS1/2 is sufficient for colonic tropism and persistence, J. Virol., 87, 327, 10.1128/JVI.01864-12 Nice, 2015, Interferon-λ cures persistent murine norovirus infection in the absence of adaptive immunity, Science, 347, 269, 10.1126/science.1258100 Numasaki, 2007, IL-28 elicits antitumor responses against murine fibrosarcoma, J. Immunol., 178, 5086, 10.4049/jimmunol.178.8.5086 O’Brien, 2014, IFN-λ4: the paradoxical new member of the interferon lambda family, J. Interferon Cytokine Res., 34, 829, 10.1089/jir.2013.0136 Odendall, 2015, The unique regulation and functions of type III interferons in antiviral immunity, Curr. Opin. Virol., 12, 47, 10.1016/j.coviro.2015.02.003 Odendall, 2014, Diverse intracellular pathogens activate type III interferon expression from peroxisomes, Nat. Immunol., 15, 717, 10.1038/ni.2915 Okabayashi, 2011, Type-III interferon, not type-I, is the predominant interferon induced by respiratory viruses in nasal epithelial cells, Virus Res., 160, 360, 10.1016/j.virusres.2011.07.011 Onoguchi, 2007, Viral infections activate types I and III interferon genes through a common mechanism, J. Biol. Chem., 282, 7576, 10.1074/jbc.M608618200 Osterlund, 2007, IFN regulatory factor family members differentially regulate the expression of type III IFN (IFN-lambda) genes, J. Immunol., 179, 3434, 10.4049/jimmunol.179.6.3434 Pagliaccetti, 2010, Interferon-λ in HCV Infection and Therapy, Viruses, 2, 1589, 10.3390/v2081589 Park, 2012, IL-29 is the dominant type III interferon produced by hepatocytes during acute hepatitis C virus infection, Hepatology, 56, 2060, 10.1002/hep.25897 Perera, 2012, Psoriasis, Annu. Rev. Pathol., 7, 385, 10.1146/annurev-pathol-011811-132448 Pestka, 2007, The interferons: 50 years after their discovery, there is much more to learn, J. Biol. Chem., 282, 20047, 10.1074/jbc.R700004200 Pietilä, 2010, Inhibition of dynamin-dependent endocytosis interferes with type III IFN expression in bacteria-infected human monocyte-derived DCs, J. Leukoc. Biol., 88, 665, 10.1189/jlb.1009651 Pott, 2011, IFN-lambda determines the intestinal epithelial antiviral host defense, Proc. Natl. Acad. Sci. USA, 108, 7944, 10.1073/pnas.1100552108 Prokunina-Olsson, 2013, A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus, Nat. Genet., 45, 164, 10.1038/ng.2521 Qi, 2010, Intron-containing type I and type III IFN coexist in amphibians: refuting the concept that a retroposition event gave rise to type I IFNs, J. Immunol., 184, 5038, 10.4049/jimmunol.0903374 Reuter, 2014, Antiviral activity of lambda interferon in chickens, J. Virol., 88, 2835, 10.1128/JVI.02764-13 Rigby, 2015, RNA degradation in antiviral immunity and autoimmunity, Trends Immunol., 36, 179, 10.1016/j.it.2015.02.001 Russell, 2014, Interferon lambda genetic polymorphisms and viral infection: the tip of the iceberg?, DNA Cell Biol., 33, 60, 10.1089/dna.2013.2261 Sabat, 2010, IL-10 family of cytokines, Cytokine Growth Factor Rev., 21, 315, 10.1016/j.cytogfr.2010.11.001 Sato, 2006, Antitumor activity of IFN-lambda in murine tumor models, J. Immunol., 176, 7686, 10.4049/jimmunol.176.12.7686 Sato, 2015, The RNA sensor RIG-I dually functions as an innate sensor and direct antiviral factor for hepatitis B virus, Immunity, 42, 123, 10.1016/j.immuni.2014.12.016 Sheahan, 2014, Interferon lambda alleles predict innate antiviral immune responses and hepatitis C virus permissiveness, Cell Host Microbe, 15, 190, 10.1016/j.chom.2014.01.007 Sheppard, 2003, IL-28, IL-29 and their class II cytokine receptor IL-28R, Nat. Immunol., 4, 63, 10.1038/ni873 Shindo, 2013, IL-28B (IFN-λ3) and IFN-α synergistically inhibit HCV replication, J. Viral Hepat., 20, 281, 10.1111/j.1365-2893.2012.01649.x Siegel, 2011, Regulation of IFN-λ1 promoter activity (IFN-λ1/IL-29) in human airway epithelial cells, J. Immunol., 187, 5636, 10.4049/jimmunol.1003988 Sommereyns, 2008, IFN-lambda (IFN-lambda) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo, PLoS Pathog., 4, e1000017, 10.1371/journal.ppat.1000017 Sorgeloos, 2013, Antiviral type I and type III interferon responses in the central nervous system, Viruses, 5, 834, 10.3390/v5030834 Souza-Fonseca-Guimaraes, 2015, NK cells require IL-28R for optimal in vivo activity, Proc. Natl. Acad. Sci. USA, 112, E2376, 10.1073/pnas.1424241112 Srinivas, 2008, Interferon-lambda1 (interleukin-29) preferentially down-regulates interleukin-13 over other T helper type 2 cytokine responses in vitro, Immunology, 125, 492, 10.1111/j.1365-2567.2008.02862.x Stifter, 2015, Interfering with immunity: detrimental role of type I IFNs during infection, J. Immunol., 194, 2455, 10.4049/jimmunol.1402794 Strange, 2010, A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1, Nat. Genet., 42, 985, 10.1038/ng.694 Suppiah, 2009, IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy, Nat. Genet., 41, 1100, 10.1038/ng.447 Swider, 2014, Regulation of interferon lambda-1 (IFNL1/IFN-λ1/IL-29) expression in human colon epithelial cells, Cytokine, 65, 17, 10.1016/j.cyto.2013.09.020 Swiecki, 2011, Type I interferons: diversity of sources, production pathways and effects on immune responses, Curr. Opin. Virol., 1, 463, 10.1016/j.coviro.2011.10.026 Tanaka, 2009, Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C, Nat. Genet., 41, 1105, 10.1038/ng.449 Thomas, 2009, Genetic variation in IL28B and spontaneous clearance of hepatitis C virus, Nature, 461, 798, 10.1038/nature08463 Thomas, 2012, HCV infection induces a unique hepatic innate immune response associated with robust production of type III interferons, Gastroenterology, 142, 978, 10.1053/j.gastro.2011.12.055 Thomson, 2009, The role of transposable elements in the regulation of IFN-lambda1 gene expression, Proc. Natl. Acad. Sci. USA, 106, 11564, 10.1073/pnas.0904477106 Travar, 2014, Interferon lambda-2 levels in sputum of patients with pulmonary Mycobacterium tuberculosis infection, Scand. J. Immunol., 80, 43, 10.1111/sji.12178 Urban, 2010, IL28B genotype is associated with differential expression of intrahepatic interferon-stimulated genes in patients with chronic hepatitis C, Hepatology, 52, 1888, 10.1002/hep.23912 Witte, 2009, Despite IFN-lambda receptor expression, blood immune cells, but not keratinocytes or melanocytes, have an impaired response to type III interferons: implications for therapeutic applications of these cytokines, Genes Immun., 10, 702, 10.1038/gene.2009.72 Wobus, 2004, Replication of Norovirus in cell culture reveals a tropism for dendritic cells and macrophages, PLoS Biol., 2, e432, 10.1371/journal.pbio.0020432 Wolk, 2004, IL-22 increases the innate immunity of tissues, Immunity, 21, 241, 10.1016/j.immuni.2004.07.007 Wolk, 2013, IL-29 is produced by T(H)17 cells and mediates the cutaneous antiviral competence in psoriasis, Sci. Transl. Med., 5, 204ra129, 10.1126/scitranslmed.3006245 Wollenberg, 2003, Viral infections in atopic dermatitis: pathogenic aspects and clinical management, J. Allergy Clin. Immunol., 112, 667, 10.1016/j.jaci.2003.07.001 Wongthida, 2010, Type III IFN interleukin-28 mediates the antitumor efficacy of oncolytic virus VSV in immune-competent mouse models of cancer, Cancer Res., 70, 4539, 10.1158/0008-5472.CAN-09-4658 Zhang, 2011, Cutting edge: Ku70 is a novel cytosolic DNA sensor that induces type III rather than type I IFN, J. Immunol., 186, 4541, 10.4049/jimmunol.1003389 Zheng, 2008, Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens, Nat. Med., 14, 282, 10.1038/nm1720 Zhou, 2007, Type III interferon (IFN) induces a type I IFN-like response in a restricted subset of cells through signaling pathways involving both the Jak-STAT pathway and the mitogen-activated protein kinases, J. Virol., 81, 7749, 10.1128/JVI.02438-06 Zhou, 2011, Type III IFN receptor expression and functional characterisation in the pteropid bat, Pteropus alecto, PLoS ONE, 6, e25385, 10.1371/journal.pone.0025385 Zhou, 2011, Type III IFNs in pteropid bats: differential expression patterns provide evidence for distinct roles in antiviral immunity, J. Immunol., 186, 3138, 10.4049/jimmunol.1003115